**Study Summary**: This clinical trial is testing a new treatment called XC001 for people with chronic angina, which is chest pain due to blocked heart arteries. The trial has two parts. In the first part, only 3 patients will receive XC001 to check if it's safe. If it is, more patients will be included in the second part. Here, about 106 patients will either receive XC001 or a fake treatment (sham procedure) to see if XC001 works better. The study lasts up to 12 months, during which patients will have to attend multiple check-ups to monitor their safety and the treatment's effects.
**Key Points**:
- **Duration**: The study lasts up to 12 months.
- **Participation**: Includes regular medical check-ups and tests.
- **Eligibility**: Open to adults aged 18-85 with chronic angina and limited treatment options.
**Definitions**:
- *Chronic Angina*: Ongoing chest pain from heart issues.
- *Cardiac Catheter*: A thin tube used to deliver treatments directly to the heart.
- *CAD (Coronary Artery Disease)*: Blocked or narrowed heart arteries.
Study Summary: This clinical trial is testing a new treatment called XC001 for people with chronic angina, which is chest pain due to blocked heart arteries. The trial has two parts. In the first part, only 3 patients will receive XC001 to check if it's safe. If it is, more patients will be included in the second part. Here, about 106 patients will either receive XC001 or a fake treatment (sham procedure) to see if XC001 works better. The study lasts up to 12 months, during which patients will have to attend multiple check-ups to monitor their safety and the treatment's effects.
- Duration: The study lasts up to 12 months.
- Participation: Includes regular medical check-ups and tests.
- Eligibility: Open to adults aged 18-85 with chronic angina and limited treatment options.
Definitions:
- Chronic Angina: Ongoing chest pain from heart issues.
- Cardiac Catheter: A thin tube used to deliver treatments directly to the heart.
- CAD (Coronary Artery Disease): Blocked or narrowed heart arteries.
How understandable was the trial content above?
Hard to understand
Easy to understand